| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 121.78M | 122.53M | 117.80M | 134.18M | 120.14M |
| Gross Profit | 26.60M | 25.77M | 26.12M | 31.95M | 27.91M |
| EBITDA | 10.78M | 7.24M | 12.43M | 18.40M | 15.43M |
| Net Income | 8.80M | 8.28M | 11.42M | 11.31M | 11.84M |
Balance Sheet | |||||
| Total Assets | 154.02M | 174.89M | 170.51M | 159.14M | 153.88M |
| Cash, Cash Equivalents and Short-Term Investments | 69.67M | 95.07M | 88.22M | 74.40M | 55.00M |
| Total Debt | 1.87M | 1.89M | 1.88M | 87.00K | 122.00K |
| Total Liabilities | 12.00M | 41.18M | 10.35M | 10.54M | 13.20M |
| Stockholders Equity | 143.18M | 134.66M | 160.58M | 148.60M | 140.68M |
Cash Flow | |||||
| Free Cash Flow | 12.89M | -2.98M | 14.55M | 24.08M | 3.43M |
| Operating Cash Flow | 14.25M | -274.00K | 15.25M | 24.79M | 4.18M |
| Investing Cash Flow | -1.47M | 7.05M | -1.84M | 8.22M | 6.61M |
| Financing Cash Flow | -28.86M | -2.91M | -886.00K | -756.00K | -14.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$1.59B | 1.96 | 10.09% | ― | 13.78% | 432.26% | |
71 Outperform | HK$387.04M | 20.46 | 6.47% | ― | 14.31% | -8.40% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | HK$586.08M | 88.79 | 0.88% | 1.88% | -10.60% | ― | |
55 Neutral | HK$11.68B | -10.36 | -23.27% | 0.86% | -2.69% | -695.87% | |
53 Neutral | HK$2.85B | -7.07 | 0.82% | 0.69% | -7.11% | ― |